Clinical trial

Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload

NCT00600938

Drugs and interventions used in this trial

6 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Core Study: Deferasirox Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Core Study: Deferoxamine Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Extension: deferoxamine to deferasirox Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Extension: deferasirox to deferoxamine Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Deferasirox Normalized identity: deferasiroxView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Deferoxamine Normalized identity: deferoxamineView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-11-01

PhasePHASE2

Conditions

Transfusional Iron Overloadunresolved

Transfusional Hemosiderosisunresolved

Interventions

Core Study: DeferasiroxDRUG

Core Study: DeferoxamineDRUG

Extension: deferoxamine to deferasiroxDRUG

Extension: deferasirox to deferoxamineDRUG

DeferasiroxDRUG · verified · RxNorm: deferasirox

DeferoxamineDRUG · verified · RxNorm: deferoxamine

Sponsors & collaborators

Novartis Pharmaceuticalslead sponsor

Mapped research locations

LondonUnited Kingdom2 BangkokThailand2 TorontoOntario, Canada1 IstanbulTurkey (Türkiye)1 CairoEgypt1 LeedsUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00600938 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.